Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

Changes in Cytomegalovirus Seroprevalence in Korea for 21 Years: a Single Center Study

  • Choi, Sae Rom (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Kyung-Ran (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Dong Sub (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, Ji-Man (Department of Pediatrics, National Cancer Center) ;
  • Kim, Sun Ja (Department of Pediatrics, Cheju Halla General Hospital) ;
  • Kim, Jong Min (Department of Pediatrics, Myungji Hospital) ;
  • Oh, Soo-young (Department of Gynecology and Obstetrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, Choel-In (Department of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Chung, Doo Ryeon (Department of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Peck, Kyong Ran (Department of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, Eun-Suk (Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Yae-Jean (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2018.04.16
  • Accepted : 2018.08.28
  • Published : 2018.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Cytomegalovirus (CMV) infection is mostly asymptomatic but can be detrimental to certain hosts. We investigated changes of CMV seroprevalence in Koreans before and after the year 2000. Methods: We reviewed laboratory values of patients who were tested for CMV immunoglobulin G (IgG) at Samsung Medical Center, Seoul, Korea, from January 1995 to December 2015. Changes in seroprevalence were analyzed by gender, age, region, and tested year period (period 1, 1995-2005 vs. period 2, 2006-2015). Results: Overall CMV seropositivity was 94.1% (10,900/11,584). There was no significant difference for CMV seropositivity among the two periods (94.2% vs. 94.1%) (P=0.862). CMV seropositivity in the 11 to 20-year age group in period 2 (78.8%) was significantly lower than that of period 1 (89.9%) (P=0.001). The seropositivity of individuals aged 31-40 years (97.4%) was significantly higher than that of younger age groups (P<0.001) and lower than that of older age groups (P<0.001). Of 2,441 females of reproductive age (from 15 to 49), CMV seropositivity was 97% (2,467/2,441). The seropositivity in women aged 20-24-years was higher than that of men in the same age group (97.6% vs. 85.6%, P=0.003). No significant difference was observed among different regions. Conclusions: Overall CMV seropositivity of Koreans was estimated to be 94% and the average seropositivity of reproductive women was 97%. Monitoring of the changes in seroprevalence including the reproductive age group is needed in the future.

목적: 거대세포바이러스(Cytomegalovirus [CMV])는 정상 면역을 가진 사람에서는 대부분 불현성 감염이지만, 면역저하자 또는 태아의 선천 감염의 경우 위중한 합병증을 유발한다. 본 연구는 21년 동안의 시기 및 연령에 따른 CMV 항체 양성률을 조사하였다. 방법: 1995년 1월부터 2015년 12월까지 성균관대학교 의과대학, 삼성서울병원에서 CMV immunoglobulin G (IgG) 검사를 시행한 환자를 대상으로 하였다. 검사 결과는 성별, 연령별, 전국 지역별로 분석하였고, 두 시기에 따른 (1995-2005년; 1기, 2006-2015년; 2기) 항체 양성률의 변화를 분석하였다. 결과: 총 11,584명의 환자 중 CMV IgG 양성결과를 보인 총 환자는 10,900명 (94.1%)이었다. 전체 환자에서 두 시기에 따른 CMV 양성률의 차이는 없었다 (94.2% vs. 94.1%) (P=0.86). 10년 간격으로 비교를 했을 때 다른 연령군은 유의하지 않았으나 11-20세의 연령군의 CMV 양성률은 1기에 비해 2기에 더 낮았다 (P<0.001). 이 연령에 따른 항체 양성률 분석에서 31-40세 연령군의 항체 양성률 (97.4%)은 이보다 어린 연령군에 비하여 유의하게 높았으며 (P<0.001, odds ratio [OR]<1), 더 높은 연령군에 비하여 유의하게 낮았다 (P<0.001, OR>1). 가임기 여성은 총 2,441명이었으며 (15-49세) 이 중 CMV IgG 양성률은 2,367 (97%)명이었다. 해당 연령군의 시기별 항체 양성률의 유의한 차이는 없었다. 가임기 여성 중 20-24세의 연령군은 해당 연령의 남자에 비하여 유의한 높은 항체 양성률을 보였다 (97.6% vs. 85.6%, OR, 6.78; 95% CI, 1.585-28.968; P=0.0028). 지역별 항체 양성률의 큰 차이는 보이지 않았다. 결론: 본 논문은 한국인의 전 연령의 CMV 항체 양성률 변화에 대한 조사를 시행한 최초 논문이며 전체적으로 약 94%의 높은 CMV 항체 양성률과 가임기 여성은 97%의 항체 양성률을 보이는 것으로 관찰되었다. 향후, 가임기 여성을 포함한 한국인의 CMV 항체 양성률의 변화 추세에 대한 모니터링과 국내 임산부에서의 CMV 감염에 대한 연구가 필요할 것으로 사료된다.

Keywords

References

  1. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013;26:86-102. https://doi.org/10.1128/CMR.00062-12
  2. Lanzieri TM, Kruszon-Moran D, Amin MM, Bialek SR, Cannon MJ, Carroll MD, et al. Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012. Clin Vaccine Immunol 2015;22:245-7. https://doi.org/10.1128/CVI.00697-14
  3. Adler SP. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011;2011:1-9.
  4. Enders G, Daiminger A, Lindemann L, Knotek F, Bader U, Exler S, et al. Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010. Med Microbiol Immunol (Berl) 2012;201:303-9. https://doi.org/10.1007/s00430-012-0232-7
  5. Antona D, Lepoutre A, Fonteneau L, Baudon C, Halftermeyer-Zhou F, LE Strat Y, et al. Seroprevalence of cytomegalovirus infection in France in 2010. Epidemiol Infect 2017;145:1471-8. https://doi.org/10.1017/S0950268817000103
  6. Stoykova ZD, Ivanova LI, Todorova TT. The role of cytomegalovirus in congenital and early postnatal infections in Northeastern Bulgaria. Folia Med (Plovdiv) 2017;59:298-302. https://doi.org/10.1515/folmed-2017-0036
  7. Jin Q, Su J, Wu S. Cytomegalovirus infection among pregnant women in Beijing: seroepidemiological survey and intrauterine transmissions. J Microbiol Biotechnol 2017;27:1005-9. https://doi.org/10.4014/jmb.1612.12020
  8. Pancharoen C, Bhattarrakosol P, Thisyakorn U. Seroprevalence of cytomegalovirus infection in children. Southeast Asian J Trop Med Public Health 1998;29:269-72.
  9. Wong A, Tan KH, Tee CS, Yeo GS. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J 2000;41:151-5.
  10. Shigemi D, Yamaguchi S, Otsuka T, Kamoi S, Takeshita T. Seroprevalence of cytomegalovirus IgG antibodies among pregnant women in Japan from 2009-2014. Am J Infect Control 2015;43:1218-21. https://doi.org/10.1016/j.ajic.2015.06.026
  11. Chen MH, Chen PC, Jeng SF, Hsieh CJ, Su FC, Liao HF, et al. High perinatal seroprevalence of cytomegalovirus in northern Taiwan. J Paediatr Child Health 2008;44:166-9. https://doi.org/10.1111/j.1440-1754.2007.01215.x
  12. Oh YC, Choi BR, Kim CA, Cho MJ. A study for detection of IgG, IgM antibody to cytomegalovirus in blood donors. Korean J Hematol 1989;24:75-9.
  13. Park HK. Study of cytomegalovirus and herpes simplex virus antibodies in Korean pregnant women with complement fixation test. Ewha Med J 1984;7:191-7. https://doi.org/10.12771/emj.1984.7.4.191
  14. Seo SY, Park SJ, Hwang JY, Hahn SH, Kim SY, Kim HH, et al. The Alteration of the positive rate of cytomegalovirus IgG antibody among preschool period children. Korean J Pediatr 2006;49:51-5. https://doi.org/10.3345/kjp.2006.49.1.51
  15. Lee KY. Seroepidemiology of cytomegalovirus in Taejon, Korea, in 1996. J Korean Pediatr Soc 1998;41:754-9.
  16. de Ory F, Ramirez R, Garcia Comas L, Leon P, Sagues MJ, Sanz JC. Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol 2004;19:85-9.
  17. Takemoto K, Nishimura N, Kozawa K, Hibino H, Kawaguchi M, Takeuchi S, et al. Time-series analysis comparing the prevalence of antibodies against nine viral species found in umbilical cord blood in Japan. Jpn J Infect Dis 2016;69:314-8. https://doi.org/10.7883/yoken.JJID.2015.366
  18. Korean Statistical Information Service (KOSIS). Population by census. Daejeon: Korean Statistical Information Service; 2015.
  19. Puhakka L, Renko M, Helminen M, Peltola V, Heiskanen-Kosma T, Lappalainen M, et al. Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection - register-based study from Finland. Infect Dis (Lond) 2017;49:445-53. https://doi.org/10.1080/23744235.2017.1279344
  20. Kim CS. Congenital and perinatal cytomegalovirus infection. Korean J Pediatr 2010;53:14-20. https://doi.org/10.3345/kjp.2010.53.1.14
  21. Voigt S, Schaffrath Rosario A, Mankertz A. Cytomegalovirus seroprevalence among children and adolescents in Germany: data from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003-2006. Open Forum Infect Dis 2015;3:ofv193.
  22. Taniguchi K, Watanabe N, Sato A, Jwa SC, Suzuki T, Yamanobe Y, et al. Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study. J Clin Virol 2014;59:192-4. https://doi.org/10.1016/j.jcv.2013.12.013
  23. Shim YG. Complement-fixing antibodies against Cytomegalovirus among volunteer blood donors in Seoul area. Korean J Epidemiol 1981;3:99-104.
  24. Cho YK, Shim TS. Antibody positive rate in primary school children against cytomegalovirus as detected by ELISA method. Chung Ang J Med 1982;7:407-11.
  25. Kim CH, Shim TS. Antibody posses rate of schoolgirls against rubella and cytomegalovirus by ELISA method. Chung Ang J Med 1982;7:247-52.
  26. Baek SG, Shim TS. Antibody positive rate of cytomegalovirus by ELISA in preschool children. Off J Res Med Sci Korea 1986;18:46-50.
  27. Sohn YM, Park KI, Lee C, Han DG, Lee WY. Congenital cytomegalovirus infection in Korean population with very high prevalence of maternal immunity. J Korean Med Sci 1992;7:47-51. https://doi.org/10.3346/jkms.1992.7.1.47
  28. Lee HJ, Jang SH. Prevalence of antibody to cytomegalovirus by anticomplement immunofluorescence test in Korean children. Korean J Infect Dis 1993;25:357-61.
  29. Kim YK, Kim DW. Seroepidemiology of human cytomegalovirus in healthy adults measured by means of the anticomplement immunofluorescence technique. Korean J Infect Dis 1992;24:87-92.
  30. Seo S, Cho Y, Park J. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test. Korean J Lab Med 2009;29:557-62. https://doi.org/10.3343/kjlm.2009.29.6.557

Cited by

  1. Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C vol.10, pp.None, 2019, https://doi.org/10.3389/fimmu.2019.02865
  2. Cytomegalovirus disease in a retinoblastoma cohort: The role of preemptive screening vol.67, pp.3, 2018, https://doi.org/10.1002/pbc.28101
  3. Cytomegalovirus infection after kidney transplantation during 16 years in South Korea vol.22, pp.3, 2018, https://doi.org/10.1111/tid.13310
  4. Successful treatment of refractory CMV colitis after haploidentical HSCT with post-transplant cyclophosphamide using CD45RA+ depleted donor lymphocyte infusion vol.55, pp.8, 2018, https://doi.org/10.1038/s41409-019-0685-z
  5. Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation vol.15, pp.9, 2018, https://doi.org/10.1371/journal.pone.0238257
  6. Clinical utility of aqueous humor polymerase chain reaction and serologic testing for suspected infectious uveitis: a single-center retrospective study in South Korea vol.20, pp.1, 2018, https://doi.org/10.1186/s12886-020-01513-x
  7. Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia vol.36, pp.19, 2018, https://doi.org/10.3346/jkms.2021.36.e128
  8. Serosurvey of parvovirus B19 and cytomegalovirus infections among female university students in Shiraz, Southern Iran vol.42, pp.2, 2021, https://doi.org/10.1080/15321819.2020.1862860
  9. Cytomegalovirus Infection Mimicking Recurrence of Malignant Lymphoma: A Case Report vol.28, pp.1, 2018, https://doi.org/10.15264/cpho.2021.28.1.58
  10. Disseminated Postnatal Cytomegalovirus Infection in a Preterm Neonate: Autopsy Case Report vol.28, pp.2, 2018, https://doi.org/10.5385/nm.2021.28.2.83